Fully human glyco-optimized recombinant FSH (follitropin epsilon) - a randomized, comparator-controlled phase 2 clinical trial
Conclusions75 IU of daily follitropin epsilon results in similar ovarian response as compared to a standard dose of 150 IU follitropin alfa. This dose could be tested in phase III.
Source: Reproductive BioMedicine Online - Category: Reproduction Medicine Source Type: research
More News: Clinical Trials | Estradiol | Eyes | Hormones | Nutrition | Ovaries | Reproduction Medicine | Study | Women